An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome

Fecal Markers: Calprotectin and Lactoferrin

(2012) Bincy P. Abraham et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome

(2011) H. M. Staudacher et al.   JOURNAL OF HUMAN NUTRITION AND DIETETICS

Impact of the synbiotic combination of Lactobacillus casei shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in healthy subjects

(2011) Vicky De Preter et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Solid-Phase Microextraction and the Human Fecal VOC Metabolome

(2011) Emma Dixon et al.   PLoS One

Validation of Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: A Critical Review

(2010) William E Whitehead et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

(2010) Savio C Reddymasu et al.   BMC GASTROENTEROLOGY

A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome

(2009) Caroline Codling et al.   DIGESTIVE DISEASES AND SCIENCES

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

(2009) Valle García-Sánchez et al.   Journal of Crohns & Colitis

Analysis of Faecal Volatile Organic Compounds in Preterm Infants Who Develop Necrotising Enterocolitis: A Pilot Study

(2009) Catherine E Garner et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis

(2009) C.E. Garner et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Elevated pro-inflammatory and lipotoxic mucosal lipidscharacterise irritable bowel syndrome

(2009) Kajsa Kajander et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

(2008) Charlotte M.T. Otten et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

(2008) J.P. Gisbert et al.   DIGESTIVE AND LIVER DISEASE

Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry

(2008) Ruyi Xue et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

An analysis of volatiles in the headspace of the faeces of neonates

(2008) B De Lacy Costello et al.   Journal of Breath Research

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES